Z
Zeqi Zhou
Researcher at Bayer Corporation
Publications - 11
Citations - 295
Zeqi Zhou is an academic researcher from Bayer Corporation. The author has contributed to research in topics: Epitope & Antigen. The author has an hindex of 6, co-authored 9 publications receiving 292 citations.
Papers
More filters
Journal ArticleDOI
Novel immunoassay for the measurement of complexed prostate-specific antigen in serum
TL;DR: Both the serum concentration and the proportion of complexed PSA was substantially higher in patients with CaP compared with patients with benign prostate disease, and the cPSA assay may have utility in improving specificity in screening for prostate cancer.
Journal ArticleDOI
Summary Report of the TD-3 Workshop: Characterization of 83 Antibodies against Prostate-Specific Antigen
U.-H. Stenman,Elisabeth Paus,W.J. Allard,I Andersson,C. Andrés,T.R. Barnett,Charlotte Becker,A. Belenky,L. Bellanger,C.M. Pellegrino,Ole P. Børmer,G. Davis,Barry L. Dowell,L.S. Grauer,D.C. Jette,B Karlsson,F.T. Kreutz,T M van der Kwast,L. Lauren,M. Leinimaa,Jari Leinonen,Hans Lilja,H.J. Linton,M. Nap,O. Nilsson,P.C. Ng,K. Nustad,A Peter,Kim Pettersson,Timo Piironen,J. Rapp,Harry G. Rittenhouse,Phil D. Rye,P. Seguin,J. Slota,R.L. Sokoloff,Mavanur R. Suresh,D L Very,T.J. Wang,Ingrid Wigheden,Robert L. Wolfert,K.K. Yeung,W-M Zhang,Zeqi Zhou,J. Hilgers +44 more
TL;DR: The characterization of antibodies from this workshop and the location of their epitopes on the 3-D model of PSA illustrate the importance of selecting appropriate antibody pairs for use in immunoassays.
Patent
Determination of cpsa
TL;DR: A method for determining the complexed forms of immunologically determinable prostate specific antigen (cPSA) in a blood sample, e.g., by two-site immunometric assays, in which the blood sample is treated to render free PSA immunologically nondetectable, is described in this paper.
Journal ArticleDOI
Technicon Immuno 1® PSA assay measures both free and alpha‐1‐antichymotrypsin‐complexed prostate‐specific antigen on an equimolar basis
TL;DR: Results demonstrate that the Technicon Immuno 1® PSA assay measures free and ACT‐complexed PSA on an equal molar basis.
Journal ArticleDOI
Multicenter evaluation of the performance and clinical utility in longitudinal monitoring of the Bayer Immuno 1 complexed PSA assay.
W. J. Allard,Carol D. Cheli,Deborah L. Morris,Joan L. Goldblatt,Pierre Y,Linda Kish,Chen Y,Dai J,Robert L. Vessella,Daniel W. Chan,Morton K. Schwartz,Zeqi Zhou,Kwok K. Yeung +12 more
TL;DR: The Bayer Immuno 1 cPSA assay demonstrates analytical performance and clinical effectiveness in the management of prostate cancer patients during the course of disease and therapy.